Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""EUROPEAN Union"" wg kryterium: Temat


Tytuł :
New Frontiers of Dispute Settlement in a Pillar One World--Part One: We're witnessing an increased convergence of tax and trade in corporate risk management.
Autorzy :
Davis, J. Brian
Baumgarten Jr., Ronald J.
Pokaż więcej
Temat :
EUROPEAN Union
UNITED Nations
DOUBLE tax agreements
INDUSTRIAL management
TRANSFER pricing
DISPUTE resolution
CORPORATE taxes
FOREIGN tax credit
INTERNATIONAL taxation
Źródło :
Tax Executive. Mar/Apr2022, Vol. 74 Issue 2, p60-71. 12p.
Periodyk
Tytuł :
Pharmaceutical patenting in the European Union: reform or riddance.
Autorzy :
Garattini L; Institute for Pharmacological Research Mario Negri IRCCS, Ranica, BG, Italy. .
Badinella Martini M; Institute for Pharmacological Research Mario Negri IRCCS, Ranica, BG, Italy.
Mannucci PM; IRCCS 'Ca' Granda Maggiore Policlinico' Hospital Foundation, Milan, Italy.
Pokaż więcej
Źródło :
Internal and emergency medicine [Intern Emerg Med] 2022 Apr; Vol. 17 (3), pp. 937-939. Date of Electronic Publication: 2021 Nov 15.
Typ publikacji :
Letter
MeSH Terms :
European Union*
Humans ; Pharmaceutical Preparations
Opinia redakcyjna
Tytuł :
Microbial biostimulants - the need for clarification in EU regulation.
Autorzy :
Hendriksen NB; DCE - Danish Centre for Environment and Energy, Department of Environmental Science, Aarhus University, Aarhus, Denmark. Electronic address: .
Pokaż więcej
Źródło :
Trends in microbiology [Trends Microbiol] 2022 Apr; Vol. 30 (4), pp. 311-313. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji :
Journal Article
MeSH Terms :
European Union*
Phylogeny
Czasopismo naukowe
Tytuł :
Time is running out for COVID vaccine patent waivers.
Źródło :
Nature [Nature] 2022 Mar; Vol. 603 (7903), pp. 764.
Typ publikacji :
Editorial
MeSH Terms :
European Union*
International Cooperation*/legislation & jurisprudence
COVID-19 Vaccines/*supply & distribution
Patents as Topic/*legislation & jurisprudence
COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines/economics ; Humans ; Licensure ; Organizations ; Time Factors
Opinia redakcyjna
Tytuł :
Phase I studies in EU: due change in compliance and transparency under the EU clinical trials regulation.
Autorzy :
De Mey CM; ACPS - Applied Clinical Pharmacology Services, Viktoriastrasse 4, 65189, Wiesbaden, Germany. .
Pokaż więcej
Źródło :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Jun; Vol. 78 (6), pp. 1047-1048. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji :
Letter
MeSH Terms :
European Union*
Humans
Opinia redakcyjna
Tytuł :
Anywheres, Somewheres, local attachment, and civic participation.
Autorzy :
Chan TW; Social Research Institute, University College London, London, UK.
Kawalerowicz J; Department of Human Geography, Stockholm University, Stockholm, Sweden.
Pokaż więcej
Źródło :
The British journal of sociology [Br J Sociol] 2022 Jan; Vol. 73 (1), pp. 112-124. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article
MeSH Terms :
European Union*
Humans ; United Kingdom
Czasopismo naukowe
Tytuł :
Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks.
Autorzy :
Vogeser M; Institute of Laboratory Medicine, University Hospital, LMU Munich, Germany.
Brüggemann M; Department of Hematology, University Hospital Schleswig Holstein, Kiel, Germany.
Lennerz J; Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Gassner UM; Institute of Medical Device Law, Faculty of Law, University of Augsburg, Germany.
Pokaż więcej
Źródło :
Clinical chemistry [Clin Chem] 2021 Dec 30; Vol. 68 (1), pp. 40-42.
Typ publikacji :
Journal Article
MeSH Terms :
European Union*
Humans
Czasopismo naukowe
Tytuł :
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
Autorzy :
Correia Pinheiro L; European Medicines Agency (EMA), Amsterdam, The Netherlands.
Giezen TJ; Foundation Pharmacy for Hospitals in Haarlem, Haarlem, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands.; Biosimilar Medicinal Products Working Party (BMWP), European Medicines Agency, Amsterdam, The Netherlands.
Wolff-Holz E; Biosimilar Medicinal Products Working Party (BMWP), European Medicines Agency, Amsterdam, The Netherlands.; Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.
Weise M; Biosimilar Medicinal Products Working Party (BMWP), European Medicines Agency, Amsterdam, The Netherlands.; Paul-Ehrlich-Institut, Langen, Germany.; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency, Amsterdam, The Netherlands.
Laslop A; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency, Amsterdam, The Netherlands.; Bundesamt für Sicherheit im Gesundheitswesen (BASG), Vienna, Austria.
Hidalgo-Simon A; European Medicines Agency (EMA), Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1311-1317. Date of Electronic Publication: 2021 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Adverse Drug Reaction Reporting Systems*/statistics & numerical data
Databases, Factual*/statistics & numerical data
European Union*/statistics & numerical data
Biological Factors/*adverse effects
Biosimilar Pharmaceuticals/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/standards ; Biological Factors/standards ; Biosimilar Pharmaceuticals/standards ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Humans ; Pharmacovigilance ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Rituximab/adverse effects
Czasopismo naukowe
Tytuł :
Landscape fragmentation of the Natura 2000 network and its surrounding areas.
Autorzy :
Lawrence A; Department of Biogeography, University of Bayreuth, Bayreuth, Germany.
Friedrich F; Department of Biogeography, University of Bayreuth, Bayreuth, Germany.
Beierkuhnlein C; Department of Biogeography, University of Bayreuth, Bayreuth, Germany.; BayCEER, Bayreuth Center for Ecology and Environmental Research, Bayreuth, Germany.; GIB, Bayreuth Institute for Geography, Bayreuth, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Oct 21; Vol. 16 (10), pp. e0258615. Date of Electronic Publication: 2021 Oct 21 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biodiversity*
Conservation of Natural Resources*
Ecosystem*
European Union*
Environmental Monitoring
Czasopismo naukowe
Tytuł :
Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches.
Autorzy :
Rei Bolislis W; Sanofi R&D, Chilly-Mazarin, France.
Bejeuhr G; Bayer AG R&D Pharmaceuticals, Berlin, Germany.
Benzaghou F; Ipsen, Cambridge, Massachusetts, USA.
Corriol-Rohou S; AstraZeneca, Courbevoie, France.
Herrero-Martinez E; AbbVie Ltd., Berkshire, UK.
Hildebrand H; Bayer AG R&D Pharmaceuticals, Berlin, Germany.
Hill-Venning C; Janssen-Cilag Ltd., Buckinghamshire, UK.
Hoogland H; Leo Pharma A/S, Ballerup, Denmark.
Johnson C; GlaxoSmithKline Research & Development Ltd., Middlesex, UK.
Joos A; MSD (Europe) Inc., Brussels, Belgium.
Vart R; Eli Lilly and Company Limited, Windlesham, Surrey, UK.
Le Visage G; Novartis Pharma AG, Basel, Switzerland.
Kühler TC; Sanofi R&D, Chilly-Mazarin, France.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Oct; Vol. 110 (4), pp. 871-879. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
European Union*
Pediatrics*
Drug Development/*legislation & jurisprudence
Drug Development/standards ; Drug and Narcotic Control ; Guideline Adherence ; Guidelines as Topic ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies